1 |
C. Huang, R. Kimura, R Nasser and A.A. Hussain, Mechanism of nasal absorption of drugs I : physicochemical parameters influencing the rate of in-situ nasal absorption of drugs in rats, J. Pharm. Sci., 74, 608-611 (1985)
DOI
|
2 |
K.S.E. Su, K.M. Campanale and C.L. Gries, Nasal drug delivery system of a quaternary ammonium compound : clofilium tosylate, J. Pharm. Sci., 73, 1251-1254 (1984)
DOI
|
3 |
T. Sakane, M. Akizuki and M. Yoshida, Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity, J. Pharm. Pharmacol., 43, 449-451 (1990)
|
4 |
A.A. Hussain, A. Dakkuri and S. Itoh, Nasal absorption of ondansetron in rats : an alternative route of drug delivery, Cancer Chemother. Pharmacol., 45, 432-434 (2000)
DOI
|
5 |
P. Dondeti, H. Zia and T.E. Needham, Bioadhesive and formulation parameters affecting nasal absorption, Int. J. Pharm., 127, 115-133 (1996)
DOI
ScienceOn
|
6 |
G.J. Sanger and D.R. Nelson, Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron), Eur. J. Pharmacol., 159, 113-124 (1989)
DOI
ScienceOn
|
7 |
International Conference on Harmonizaton, Note for Guidance on Validation of Analytical Procedures : Methodology, Committee for Proprietary Medical Products, CPMP/ICH/281/95, Approval 18 December 1996
|
8 |
J.W. Upward, B.D. Arnold, C. Link, D.M. Pierce, A. Allen and T.C. Tasker, The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist, Eur. J. Cancer, 26, S12-S15 (1990)
|
9 |
J. Carmichael, B.M. Cantwell, C.M. Edwards, B.D. Zussman, S. Thompson, W.G. Rapeport and A.L. Harris, A pharma- cokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response, Cancer Chemother. Pharmacol., 24, 45-49 (1989)
|
10 |
L.L. Brunton, J.S. Lazo and K.L. Parker, A Goodman & Gilman? The Pharmacological basis of Therapeutics, 11th ed., McGRAW-HILL Medical Publishing division. 1830-1831 (2006)
|
11 |
R.L. Smith, R.E. Smyth, B.D. Keck, G.O. Kinnett and C.A. Cruze, Effect of formulation and dosing variables on the intranasal absorption of loperamide in the rat, Pharm. Res., 9, S-207 (1992)
|
12 |
T. Sakane, M. Akizuki, S. Yamashida, T. Nadia, M. Hashida and H. Sezaki, The transport of a drug to the cerebrospinal fluid directly from the nasal cavity : the relation to the lipiphilicity of the drug, Chem. Pharm. Bull., 39, 2456-2458 (1991)
DOI
ScienceOn
|
13 |
C.-T. Huang, K.-C. Chen and T.-H. Tsai, Simultaneous measurement of blood and brain microdialysates of granisetron in rat by high-performance liquid chromato- graphy with fluorescence detection, J. Chromatogr. B, 716, 251-255 (1998)
DOI
ScienceOn
|
14 |
L. Illum, Nasal drug delivery: possibilities, problems and solutions, J. Control. Rel., 87, 187-198 (2003)
DOI
ScienceOn
|
15 |
A.A. Hussain, S. Hirai and R. Bawarshi, Nasal absorption of propranolol from different dosage forms by rats and dogs, J. Pharm. Sci., 69, 1411-1412 (1980)
DOI
|